abstract
- We asked three experts which antiretroviral regimen they would recommend next for a patient with triple-class resistance and low viremia--and got three different answers.
Antiretroviral rounds. Too many options?
Overview
authors
publication date
- February 1, 2009
published in
- AIDS clinical care Journal
Research
keywords
- HIV Infections
- HIV Protease Inhibitors
- Reverse Transcriptase Inhibitors
Identity
Scopus Document Identifier
- 61549143009
PubMed ID
- 19253449
Additional Document Info
volume
- 21
issue
- 2